Corbus Pharmaceuticals Holdings, Inc.
CRBP
21 insider filings · Latest: Jun 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 11 8:30 PM | Winston KungDirector | Sale | 2,026 | $7.91 | $16.0K | 12,140(D) | View → |
| Jun 10, 2026 | Jun 11 8:30 PM | Anne AltmeyerDirector | Sale | 2,412 | $7.91 | $19.1K | 7,579(D) | View → |
| Jun 10, 2026 | Jun 11 8:30 PM | John Kenneth JenkinsDirector | Sale | 4,800 | $7.91 | $38.0K | 3,833(D) | View → |
| Jun 3, 2026 | Jun 3 9:36 PM | Nishant C SaxenaChief Business Officer | Purchase | 9,000 | $7.58 | $68.2K | 75,300(D) | View → |
| Jun 2, 2026 | Jun 3 9:36 PM | Nishant C SaxenaChief Business Officer | Purchase | 4,500 | $7.33 | $33.0K | 66,300(D) | View → |
| Mar 2, 2026 | Mar 4 9:30 PM | Dominic SmethurstChief Medical Officer | Sale | 6,097 | $8.30 | $50.6K | 89,790(D) | View → |
| Mar 2, 2026 | Mar 2 9:08 PM | Smethurst Dominic | Proposed Sale | 6,097 | $8.30 | $50.6K | — | View → |
| Feb 17, 2026 | Feb 18 9:32 PM | Ian HodgsonChief Operating Officer | Sale | 847 | $7.38 | $6.3K | 51,080(D) | View → |
| Feb 13, 2026 | Feb 18 9:31 PM | Sean F. MoranChief Financial Officer | Sale | 4,701 | $7.78 | $36.6K | 96,694(D) | View → |
| Feb 13, 2026 | Feb 18 9:30 PM | Yuval CohenDirector, Chief Executive Officer | Sale | 13,871 | $7.78 | $108.0K | 174,316(D) | View → |
| Feb 13, 2026 | Feb 13 9:02 PM | Cohen Yuval | Proposed Sale | 20,000 | $40.63 | $812.6K | — | View → |
| Feb 3, 2026 | Feb 4 9:25 PM | Dominic SmethurstChief Medical Officer | Sale | 3,285 | $8.09 | $26.6K | 95,887(D) | View → |
| Feb 3, 2026 | Feb 4 9:24 PM | Ian HodgsonChief Operating Officer | Sale | 2,415 | $8.09 | $19.5K | 51,927(D) | View → |
| Oct 24, 2025 | Oct 24 8:18 PM | Cohen Yuval | Proposed Sale | 27,633 | $17.01 | $470.0K | — | View → |
| Oct 24, 2025 | Oct 24 8:14 PM | Moran Sean F. | Proposed Sale | 12,981 | $17.02 | $220.9K | — | View → |
| Mar 6, 2025 | Mar 6 9:03 PM | Smethurst Dominic | Proposed Sale | 6,393 | $6.84 | $43.7K | — | View → |
| Feb 14, 2025 | Feb 14 9:18 PM | Moran Sean F. | Proposed Sale | 2,792 | $9.48 | $26.5K | — | View → |
| Feb 14, 2025 | Feb 14 9:16 PM | Cohen Yuval | Proposed Sale | 7,134 | $9.48 | $67.6K | — | View → |
| Sep 4, 2024 | Sep 4 8:44 PM | CATLIN AVERY W | Proposed Sale | 888 | $56.43 | $50.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 22 8:51 PM | Nishant C SaxenaChief Business Officer | Grant/Award | 192,300 | $11.51 | 192,300(D) | View → |
| May 19, 2026 | May 21 9:07 PM | Winston KungDirector | Grant/Award | 12,300 | $9.15 | 12,300(D) | View → |
| May 19, 2026 | May 21 9:06 PM | Rachelle Suzanne JacquesDirector | Grant/Award | 12,300 | $9.15 | 12,300(D) | View → |
| May 19, 2026 | May 21 9:06 PM | John Kenneth JenkinsDirector | Grant/Award | 12,300 | $9.15 | 12,300(D) | View → |
| May 19, 2026 | May 21 9:05 PM | Anne AltmeyerDirector | Grant/Award | 12,300 | $9.15 | 12,300(D) | View → |
| May 19, 2026 | May 21 9:05 PM | Yong BenDirector | Grant/Award | 12,300 | $9.15 | 12,300(D) | View → |
| May 19, 2026 | May 21 9:04 PM | Brent PfeiffenbergerDirector | Grant/Award | 24,700 | $9.15 | 24,700(D) | View → |
| Jan 14, 2026 | Jan 16 9:30 PM | Dominic SmethurstChief Medical Officer | Grant/Award | 85,095 | $8.26 | 85,095(D) | View → |
| Jan 14, 2026 | Jan 16 9:30 PM | Sean F. MoranChief Financial Officer | Grant/Award | 84,247 | $8.26 | 84,247(D) | View → |
| Jan 14, 2026 | Jan 16 9:30 PM | Yuval CohenDirector, Chief Executive Officer | Grant/Award | 150,000 | $8.26 | 150,000(D) | View → |
| Jan 14, 2026 | Jan 16 9:30 PM | Ian HodgsonChief Operating Officer | Grant/Award | 85,095 | $8.26 | 85,095(D) | View → |